Insider Transactions in Q3 2025 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 09
2025
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
32,979
-8.19%
|
$494,685
$15.69 P/Share
|
|
Jul 09
2025
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
30,250
-19.12%
|
$453,750
$15.69 P/Share
|
|
Jul 08
2025
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+17.85%
|
-
|
|
Jul 08
2025
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+27.5%
|
-
|